Does ROMIDEPSIN Cause Peripheral t-cell lymphoma unspecified? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Peripheral t-cell lymphoma unspecified have been filed in association with ROMIDEPSIN (Romidepsin). This represents 8.0% of all adverse event reports for ROMIDEPSIN.
102
Reports of Peripheral t-cell lymphoma unspecified with ROMIDEPSIN
8.0%
of all ROMIDEPSIN reports
73
Deaths
18
Hospitalizations
How Dangerous Is Peripheral t-cell lymphoma unspecified From ROMIDEPSIN?
Of the 102 reports, 73 (71.6%) resulted in death, 18 (17.6%) required hospitalization, and 6 (5.9%) were considered life-threatening.
Is Peripheral t-cell lymphoma unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMIDEPSIN. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does ROMIDEPSIN Cause?
Nausea (91)
Death (90)
Thrombocytopenia (90)
Pyrexia (77)
Drug ineffective (69)
Anaemia (61)
Electrocardiogram qt prolonged (61)
Platelet count decreased (60)
Vomiting (57)
Fatigue (55)
What Other Drugs Cause Peripheral t-cell lymphoma unspecified?
BRENTUXIMAB VEDOTIN (89)
CYCLOPHOSPHAMIDE (65)
DOXORUBICIN (64)
PREDNISONE (53)
VINCRISTINE (38)
METHOTREXATE (37)
PREDNISOLONE (34)
RITUXIMAB (32)
ETOPOSIDE (26)
TACROLIMUS (22)
Which ROMIDEPSIN Alternatives Have Lower Peripheral t-cell lymphoma unspecified Risk?
ROMIDEPSIN vs ROMIPLOSTIM
ROMIDEPSIN vs ROMOSOZUMAB
ROMIDEPSIN vs ROMOSOZUMAB-AQQG
ROMIDEPSIN vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIDEPSIN vs ROPINIROLE